Myriad Genetics MYGN Sales & Marketing
Sales & Marketing at other companies
Other financials
Where this comes from
Reported directly by Myriad Genetics in its filing.
Tagged under the XBRL concept us-gaap:SellingAndMarketingExpense.
The official record: Myriad Genetics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Myriad Genetics's sales & marketing.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Myriad Genetics's sales & marketing?
- Myriad Genetics (MYGN) reported sales & marketing of $73.6M in Q1 2026.
- How has Myriad Genetics's sales & marketing changed year-over-year?
- Myriad Genetics's sales & marketing increased by 6.4% year-over-year, from $69.2M to $73.6M.
- What is the long-term trend for Myriad Genetics's sales & marketing?
- Over 3 years (2022 to 2025), Myriad Genetics's sales & marketing has grown at a 1.7% compound annual growth rate (CAGR), from $266.8M to $280.8M.
- What does sales & marketing mean?
- Costs of selling products and services including sales force compensation, commissions, marketing campaigns, trade shows, and customer acquisition expenses.